A novel deep intronic EIF2AK3 variant disrupts splicing and causes Wolcott-Rallison syndrome.
- DOI
- 10.1111/dme.70466
- Published
- 2026-09-03
- Container
- Diabet Med
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dme.70466,
title = {A novel deep intronic EIF2AK3 variant disrupts splicing and causes Wolcott-Rallison syndrome.},
author = {Al Assi A and Bonfield G and Russ-Silsby J and Ahmed S and Laver TW and Karaer K and Özhan B and Altincik A and Patel KA and Houghton JAL and Flanagan SE and Johnson MB and De Franco E.},
year = {2026},
journal = {Diabet Med},
doi = {10.1111/dme.70466},
url = {https://doi.org/10.1111/dme.70466}
}RIS
TY - JOUR TI - A novel deep intronic EIF2AK3 variant disrupts splicing and causes Wolcott-Rallison syndrome. AU - Al Assi A AU - Bonfield G AU - Russ-Silsby J AU - Ahmed S AU - Laver TW AU - Karaer K AU - Özhan B AU - Altincik A AU - Patel KA AU - Houghton JAL AU - Flanagan SE AU - Johnson MB AU - De Franco E. PY - 2026 JO - Diabet Med DO - 10.1111/dme.70466 UR - https://doi.org/10.1111/dme.70466 ER -
APA
A, A. A., G, B., J, R., S, A., TW, L., K, K., B, Ö., A, A., KA, P., JAL, H., SE, F., MB, J., & E., D. F. (2026). A novel deep intronic EIF2AK3 variant disrupts splicing and causes Wolcott-Rallison syndrome.. Diabet Med. https://doi.org/10.1111/dme.70466
Source records
- europe-pmc · retrieved 2026-09-24T20:42:14.613Z